SEKISUI Launches FDA-Cleared COVID-19 and Flu Combo Test
San Diego, California, USA, October 22, 2026 SEKISUI Diagnostics has announced the launch of its OSOMĀ® COVID-19/Flu A&B Combo...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
San Diego, California, USA, October 22, 2026 SEKISUI Diagnostics has announced the launch of its OSOMĀ® COVID-19/Flu A&B Combo...
TOKYO, Japan, July 23, 2026 The Global Health Innovative Technology (GHIT) Fund has announced an investment of approximately JPY...
